{
  "meta": {
    "title": "Neurodegenerative_Disorders",
    "url": "https://brainandscalpel.vercel.app/neurodegenerative-disorders-bca7b059.html",
    "scrapedAt": "2025-11-29T18:31:40.457Z"
  },
  "questions": [
    {
      "id": 15466,
      "choices": [
        {
          "id": 61824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroglia </span></span></span></span></p>"
        },
        {
          "id": 61825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibroblasts</span></span></span></span></p>"
        },
        {
          "id": 61826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Axons </span></span></span></span></p>"
        },
        {
          "id": 61827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microglia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient sustains a traumatic injury resulting in damage to nervous tissue. The subsequent healing process involves the formation of scar tissue at the site of injury. Which of the following cell types is primarily responsible for the formation of scar tissue during the repair of nervous tissue?</span></span></span></span></p>",
      "unique_key": "Q3914922",
      "question_audio": null,
      "question_video": null,
      "map_id": 32467,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Neuroglia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;<strong>Gliosis </strong>is the most <strong>important histopathological indicator </strong>of <strong>CNS injury </strong>regardless of its etiology and is characterized by <strong>both hypertrophy </strong>and <strong>hyperplasia</strong>.&rdquo; The chief cell involved in this reaction is an astrocyte. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Please remember that the oligodendrocytes and the ependyma do not participate in active response to injury. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microglia </strong>is the <strong>fixed macrophage system </strong>in the <strong>CNS</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroglia</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, particularly <strong>astrocytes</strong>, are responsible for the <strong>formation of scar tissue </strong>within the <strong>central nervous system </strong>(CNS) through a <strong>process known as gliosis</strong>, which occurs in response to injury.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Fibroblasts&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are the <strong>primary cell type </strong>responsible for <strong>scar formation in peripheral tissues</strong>, but not typically within the CNS, as they produce collagen and other extracellular matrix components leading to the formation of connective tissue scars.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Axons&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">do not form scar tissue but can be i<strong>nvolved in the regeneration process </strong>in the <strong>peripheral nervous system </strong>under certain conditions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Microglia&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are the <strong>resident macrophages of the CNS</strong>, involved in the <strong>immune response </strong>and <strong>clean-up after injury </strong>but are not the <strong>primary cells </strong>responsible for scar tissue formation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>cell type </strong>primarily responsible for the <strong>formation of scar tissue </strong>during the <strong>repair of nervous tissue is Neuroglia</strong>, as <strong>astrocytes</strong>, a type of <strong>glial cell</strong>, play a crucial role in the <strong>gliosis process </strong>that leads to <strong>scar formation in the CNS</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Robbins 10th 1255</span></span></span></span></strong></p>",
      "correct_choice_id": 61824,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15512,
      "choices": [
        {
          "id": 62008,
          "text": "<p><span style=\"font-size:12pt;\">Neurofibrillary tangles</span></p>"
        },
        {
          "id": 62009,
          "text": "<p><span style=\"font-size:12pt;\">Senile neuritic plaques</span></p>"
        },
        {
          "id": 62010,
          "text": "<p><span style=\"font-size:12pt;\">Amyloid angiopathy</span></p>"
        },
        {
          "id": 62011,
          "text": "<p><span style=\"font-size:12pt;\">Lewy bodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old patient presents to the neurology clinic with a progressive decline in memory and cognitive function over the past few years. The family reports episodes of visual hallucinations and fluctuations in alertness. Cognitive testing demonstrates impaired memory recall and difficulty with executive functions. An MRI of the brain shows atrophy in the temporal and parietal lobes. Biopsy of brain tissue was done. Which of the following features is not typically associated with the pathology of this patient's condition?</span></p>",
      "unique_key": "Q1646080",
      "question_audio": null,
      "question_video": null,
      "map_id": 32470,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Lewy bodies</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Lewy bodies </strong>are <strong>not </strong>a characteristic feature of <strong>Alzheimer's disease</strong>. <strong>Alzheimer's disease </strong>is primarily characterized by the <strong>presence of neurofibrillary tangles and senile </strong>(neuritic) <strong>plaques </strong>in the <strong>brain</strong>. <strong>Amyloid angiopathy</strong>, which involves the <strong>deposition of amyloid protein in blood vessel walls</strong>, is also associated with <strong>Alzheimer's disease</strong>. However, <strong>Lewy bodies</strong> are more commonly associated with other <strong>neurodegenerative disorders</strong>, particularly <strong>Lewy body dementia </strong>and <strong>Parkinson's disease dementia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Neurofibrillary tangles</strong>: These are <strong>twisted tangles </strong>of <strong>tau protein </strong>within nerve cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: Senile (neuritic) plaques</strong>: These are <strong>abnormal clusters </strong>of <strong>beta-amyloid protein </strong>that <strong>accumulate between nerve cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Amyloid angiopathy</strong>: It involves the <strong>deposition of amyloid protein </strong>in <strong>blood vessel walls</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Lewy bodies </strong>are <strong>not </strong>typically associated with the <strong>pathology of Alzheimer's disease</strong>, which is characterized by <strong>neurofibrillary tangles</strong>, <strong>senile neuritic plaques</strong>, and <strong>amyloid angiopathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lewy bodies are intracytoplasmic eosinophilic inclusions composed of alpha-synuclein, seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Parkinson’s disease</span></li><li><span style=\"font-size:12.0pt;\">Dementia with Lewy bodies (DLB)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> / 1275</strong></span></p>",
      "correct_choice_id": 62011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15463,
      "choices": [
        {
          "id": 61812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinsonism</span></span></span></span></p>"
        },
        {
          "id": 61813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&rsquo;s disease</span></span></span></span></p>"
        },
        {
          "id": 61814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple sclerosis</span></span></span></span></p>"
        },
        {
          "id": 61815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perivenous encephalomyelitis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old patient presents with a gradual decline in memory and cognitive function over the past few years. Family members report increasing forgetfulness and difficulty with daily tasks. Neurological examination reveals no tremors or rigidity but does show signs of impaired memory recall. An MRI of the brain demonstrates atrophy in the temporal and parietal lobes. Biopsy of brain tissue reveals n</span></span><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">eurofibrillary tangles. Which condition is the patient likely to be suffering?&nbsp; </span></span></p>",
      "unique_key": "Q1306806",
      "question_audio": null,
      "question_video": null,
      "map_id": 32464,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Alzheimer&rsquo;s disease </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neurofibrillary tangles </strong>are commonly associated with <strong>Alzheimer&#39;s disease</strong>. These <strong>tangles </strong>consist of <strong>twisted filaments </strong>of <strong>tau protein</strong>, which <strong>accumulate within nerve cells </strong>and contribute to the <strong>pathology of Alzheimer&#39;s disease</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Parkinson&#39;s&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">disease is characterized by the <strong>presence of Lewy bodies</strong>, not neurofibrillary tangles.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Multiple sclerosis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involves <strong>demyelination of nerve fibers </strong>and is not typically associated with neurofibrillary tangles.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Perivenous encephalomyelitis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It may refer to <strong>inflammation around blood vessels </strong>in the <strong>brain and spinal cord</strong>, but without more specific information, it&#39;s challenging to associate it with neurofibrillary tangles.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alzheimer&#39;s disease </strong>is characterized by the <strong>presence of neurofibrillary tangles </strong>composed of <strong>tau protein </strong>within <strong>nerve cells</strong>, which are a hallmark of the <strong>disease&#39;s neuropathology.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 1278</span></span></strong></span></span></p>",
      "correct_choice_id": 61813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15464,
      "choices": [
        {
          "id": 61816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&rsquo;s disease</span></span></span></span></p>"
        },
        {
          "id": 61817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Picks disease</span></span></span></span></p>"
        },
        {
          "id": 61818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinson&rsquo;s disease</span></span></span></span></p>"
        },
        {
          "id": 61819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dementia in an old man with senile plaques is usually associated with:</span></span></span></span></p>",
      "unique_key": "Q2109596",
      "question_audio": null,
      "question_video": null,
      "map_id": 32465,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Alzheimer&rsquo;s disease </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dementia </strong>in an <strong>old man </strong>with <strong>senile plaques </strong>is typically associated with <strong>Alzheimer&#39;s disease</strong>. <strong>Senile plaques </strong>are one of the <strong>hallmark pathological features </strong>of <strong>Alzheimer&#39;s disease</strong>, consisting of <strong>extracellular deposits of beta-amyloid protein</strong>. Alzheimer&#39;s disease is the most common cause of dementia in the elderly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Pick&#39;s disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as <strong>frontotemporal dementia</strong>, is characterized by the <strong>presence of abnormal tau protein </strong>in <strong>nerve cells</strong>, but it is not typically associated with <strong>senile plaques</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Parkinson&#39;s disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It primarily involves <strong>motor symptoms such as tremors</strong>, <strong>rigidity, and bradykinesia</strong>. It is not directly associated with senile plaques.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 1275</span></span></strong></span></span></p>",
      "correct_choice_id": 61816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15465,
      "choices": [
        {
          "id": 61820,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of granulovacuolar degeneration in hippocampal neurons</span></p>"
        },
        {
          "id": 61821,
          "text": "<p><span style=\"font-size:12.0pt;\">Abundant deposition of alpha-synuclein within neurons</span></p>"
        },
        {
          "id": 61822,
          "text": "<p><span style=\"font-size:12.0pt;\">Extensive amyloid deposition in the walls of cerebral blood vessels</span></p>"
        },
        {
          "id": 61823,
          "text": "<p><span style=\"font-size:12.0pt;\">Accumulation of Hirano bodies in the hippocampus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old man with a history of progressive memory loss and cognitive decline over the past 5 years is brought to the physician by his family due to concerns about his worsening ability to perform daily tasks. The patient's Mini-Mental State Examination score has declined significantly since the last visit. An MRI of the brain shows widespread atrophy with particular emphasis in the temporal and parietal lobes. Histological examination of a biopsy specimen from the cerebral cortex reveals extracellular amyloid deposits and intraneuronal hyperphosphorylated tau protein aggregates. Which of the following additional histopathological findings would be least likely to support the likely disease in the patient?</span></p>",
      "unique_key": "Q6189634",
      "question_audio": null,
      "question_video": null,
      "map_id": 32466,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Abundant deposition of alpha-synuclein within neurons</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-synuclein </strong>is the <strong>main structural component of Lewy bodies</strong>, which are typically found in <strong>Parkinson's disease </strong>and <strong>Lewy body dementia</strong>, not in Alzheimer's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Granulovacuolar degeneration </strong>is characterized by <strong>small fluid-filled cavities </strong>containing <strong>granular debris </strong>found in the <strong>hippocampal neurons </strong>and is often seen in <strong>Alzheimer's disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;Cerebral amyloid angiopathy </strong>involves the <strong>deposition of amyloid-beta protein </strong>in the <strong>walls of small to medium-sized arteries </strong>in the <strong>central nervous system </strong>and is commonly associated with Alzheimer's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;Hirano bodies </strong>are <strong>intracellular inclusions </strong>found in the <strong>astrocytic processes </strong>that are often associated with Alzheimer's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>least likely histopathological finding </strong>to support the <strong>diagnosis of Alzheimer's disease </strong>is <strong>abundant deposition of alpha-synuclein within neurons</strong>, as this is indicative of disorders such as <strong>Parkinson's disease </strong>and <strong>Lewy body dementia</strong>, rather than Alzheimer's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Typical histological features of Alzheimer disease:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Neuritic (senile) plaques</strong>: extracellular deposits of Aβ</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurofibrillary tangles</strong>: intracellular aggregates of hyperphosphorylated tau</span></li><li><span style=\"font-size:12.0pt;\"><strong>Amyloid deposition in cerebral vessels</strong>: cerebral amyloid angiopathy → ↑ risk of hemorrhage</span></li><li><span style=\"font-size:12.0pt;\"><strong>Granulovacuolar degeneration</strong>: cytoplasmic vacuoles in hippocampal neurons</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hirano bodies</strong>: eosinophilic, rod-shaped inclusions in hippocampus (actin &amp; actin-associated proteins)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NMhnRlv.png\" width=\"848\" height=\"297\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1275</strong></span></p>",
      "correct_choice_id": 61821,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15467,
      "choices": [
        {
          "id": 61828,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinsonism</span></p>"
        },
        {
          "id": 61829,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer’s disease</span></p>"
        },
        {
          "id": 61830,
          "text": "<p><span style=\"font-size:12.0pt;\">Frontotemporal lobar degeneration</span></p>"
        },
        {
          "id": 61831,
          "text": "<p><span style=\"font-size:12.0pt;\">Huntington’s disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Tau protein are associated with all except:</span></p>",
      "unique_key": "Q1083417",
      "question_audio": null,
      "question_video": null,
      "map_id": 32468,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Huntington’s disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tau protein </strong>is primarily associated with <strong>neurodegenerative disorders </strong>characterized by <strong>tauopathy</strong>, where <strong>abnormal tau protein </strong>aggregates are found in the <strong>brain</strong>. <strong>Huntington's disease</strong>, on the other hand, is characterized by the <strong>presence of abnormal huntingtin protein aggregates</strong>, not tau protein.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4Yi9HDi.png\" width=\"992\" height=\"427\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/27/screenshot-2024-04-27-175112.png\" alt=\"\" width=\"900\" height=\"604\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1285</strong></span></p>",
      "correct_choice_id": 61831,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15468,
      "choices": [
        {
          "id": 61832,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 61833,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 61834,
          "text": "<p><span style=\"font-size:12.0pt;\">12</span></p>"
        },
        {
          "id": 61835,
          "text": "<p><span style=\"font-size:12.0pt;\">19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old patient presents with a progressive decline in memory and cognitive function. Genetic testing reveals a polymorphism in the APOE gene, specifically the ε4 allele. This gene is implicated in the risk and susceptibility to late-onset Alzheimer's disease. Which chromosome harbours the APOE gene associated with Alzheimer's disease?</span></p>",
      "unique_key": "Q6263365",
      "question_audio": null,
      "question_video": null,
      "map_id": 32469,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 19</strong></span></p><p>&nbsp;</p><p><strong>Option D:</strong></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In <strong>familial Alzheimer disease </strong>and <strong>Down syndrome</strong>, the <strong>gene encoding APP on chromosome 21 </strong>is <strong>involved</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>genetic locus on chromosome 19 </strong>that <strong>encodes apolipoprotein E </strong>(ApoE) has a <strong>strong influence on the risk of developing AD</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>APOE gene </strong>associated with <strong>Alzheimer's disease </strong>is located on <strong>chromosome 19</strong>. This <strong>locus </strong>has a significant <strong>impact on the likelihood </strong>of developing <strong>Alzheimer's disease</strong>, particularly the <strong>ε4 allele</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Three common alleles: <strong>ε2, ε3, ε4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>ε4</strong> → increases risk &amp; lowers age of onset</span></li><li><span style=\"font-size:12.0pt;\"><strong>ε2</strong> → may be protective</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>APOE’s main role</strong>: lipid transport and neuronal repair; also affects amyloid beta metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_j7fWIr5.png\" width=\"852\" height=\"253\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1285</strong></span></p>",
      "correct_choice_id": 61835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15482,
      "choices": [
        {
          "id": 61888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></span></span></span></p>"
        },
        {
          "id": 61889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine</span></span></span></span></p>"
        },
        {
          "id": 61890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GABA (Gamma-aminobutyric acid)</span></span></span></span></p>"
        },
        {
          "id": 61891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male presents with a resting tremor, bradykinesia, and rigidity. On examination, there is a characteristic &quot;pill-rolling&quot; tremor observed. The patient also exhibits postural instability. Which neurotransmitter is primarily affected in the pathophysiology of Parkinson&#39;s disease?</span></span></p>",
      "unique_key": "Q4098651",
      "question_audio": null,
      "question_video": null,
      "map_id": 32471,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson&#39;s disease </strong>is a <strong>neurodegenerative disorder </strong>characterized by the <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>. The <strong>loss of dopamine-producing neurons </strong>leads to the <strong>classic motor symptoms </strong>of <strong>resting tremor</strong>, <strong>bradykinesia</strong>, and <strong>rigidity</strong>. The characteristic <strong>&quot;pill-rolling&quot; tremor </strong>is often observed, and <strong>postural instability </strong>may develop as the disease progresses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanation</u>:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Changes </strong>in <strong>serotonin levels </strong>are more associated with <strong>mood disorders</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>imbalances in acetylcholine </strong>and <strong>dopamine </strong>play a role in <strong>movement disorders</strong>, the primary deficit in Parkinson&#39;s disease is related to dopamine deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GABA </strong>is an <strong>inhibitory neurotransmitter</strong>, and <strong>alterations in GABAergic transmission </strong>are not the primary cause of Parkinson&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>neurotransmitter primarily affected in the pathophysiology </strong>of <strong>Parkinson&#39;s disease </strong>is <strong>Dopamine</strong>, which is <strong>depleted </strong>due to <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>, leading to characteristic symptoms like <strong>resting tremor</strong>, <strong>bradykinesia, </strong>and <strong>rigidity</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1293</span></span></strong></span></span></p>",
      "correct_choice_id": 61891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15492,
      "choices": [
        {
          "id": 61928,
          "text": "<p><span style=\"font-size:12pt;\">Parietal and frontal lobe</span></p>"
        },
        {
          "id": 61929,
          "text": "<p><span style=\"font-size:12pt;\">Temporal and Parietal lobe</span></p>"
        },
        {
          "id": 61930,
          "text": "<p><span style=\"font-size:12pt;\">Temporal and occipital lobe</span></p>"
        },
        {
          "id": 61931,
          "text": "<p><span style=\"font-size:12pt;\">Parietal and occipital lobe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is affected in patients with Alzheimer’s disease?</span></p>",
      "unique_key": "Q9368123",
      "question_audio": null,
      "question_video": null,
      "map_id": 32462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Temporal and Parietal lobe</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Grossly</strong>, the <strong>brain shows a variable degree of cortical atrophy </strong>marked by <strong>widening of the cerebral sulci </strong>that is most pronounced in the <strong>frontal, temporal, and parietal lobes</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Hippocampus&nbsp;</strong>and other medial temporal lobe structures are the <strong>earliest</strong> and <strong>most severely affected</strong> in Alzheimer’s disease.</span></li><li><span style=\"font-size:12pt;\">Bradley’s Neurology mentions that.. “cortical atrophy is most pronounced in the temporal and parietal lobe with the frontal lobe involvement being later in the disease”.</span></li><li><span style=\"font-size:12pt;\">The <strong>parietal and temporal lobes</strong> are the <strong>areas most prominently affected in Alzheimer’s disease</strong>. The <strong>hippocampus</strong>, located in the <strong>medial temporal lobe</strong>, is particularly known for <strong>showing early atrophy</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Temporal lobe:</strong> especially the hippocampus: Involved in memory formation and learning. Early Alzheimer’s often presents with short-term memory loss due to hippocampal involvement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parietal lobe:</strong> Involved in spatial orientation, language, and navigation. As the disease progresses, patients may show visuospatial deficits and language disturbances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> While the <strong>parietal and frontal lobes </strong>may be <strong>affected later in Alzheimer’s disease</strong>, they are not typically the regions most affected early in the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Temporal lobe </strong>involvement is a <strong>hallmark of Alzheimer's disease</strong>, but the occipital lobe is generally spared until the later stages of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong> The <strong>occipital lobe</strong>, involved in <strong>visual processing</strong>, is typically <strong>less affected </strong>than the <strong>parietal and temporal lobes </strong>in Alzheimer’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In <strong>Alzheimer’s disease</strong>, <strong>atrophy </strong>is most <strong>pronounced in the parietal </strong>and <strong>temporal lobes</strong>, which includes the <strong>hippocampus</strong>, one of the earliest and most severely affected areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbin 10<sup>th</sup>/ 1275</strong></span></p>",
      "correct_choice_id": 61929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15493,
      "choices": [
        {
          "id": 61932,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer disease</span></span></span></p>"
        },
        {
          "id": 61933,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinson disease</span></span></span></p>"
        },
        {
          "id": 61934,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington disease</span></span></span></p>"
        },
        {
          "id": 61935,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pick disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male presents with gait problems. On examination, a key pathological feature in the substantia nigra neurons is observed, characterized by abnormal protein aggregates primarily composed of alpha-synuclein. Which of the following conditions is most likely responsible for the presence of these intracellular inclusions?</span></span></p>",
      "unique_key": "Q9680889",
      "question_audio": null,
      "question_video": null,
      "map_id": 32463,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Parkinson disease </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lewy bodies </strong>are <strong>abnormal protein aggregates </strong>primarily <strong>composed of alpha-synuclein</strong>. They are <strong>commonly found in the substantia nigra neurons </strong>in <strong>Parkinson&#39;s disease</strong>, contributing to the <strong>neurodegenerative process</strong>. These intracellular inclusions are a hallmark of Parkinson&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>Alzheimer&#39;s disease </strong>may <strong>involve abnormal protein aggregates</strong>, including <strong>beta-amyloid plaques </strong>and <strong>neurofibrillary tangles</strong>, Lewy bodies are not characteristic of Alzheimer&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Huntington&#39;s disease </strong>is characterized by the <strong>presence of huntingtin protein aggregates </strong>but not Lewy bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pick&#39;s disease </strong>is associated with <strong>frontotemporal lobar degeneration </strong>and is characterized by <strong>Pick bodies</strong>, not Lewy bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson disease </strong>is most likely responsible for the <strong>presence of these intracellular inclusions</strong>, as <strong>Lewy bodies composed of alpha-synuclein </strong>are a hallmark of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1282</span></strong></span></span></p>",
      "correct_choice_id": 61933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15522,
      "choices": [
        {
          "id": 62048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diminished calcium in the sarcoplasmic reticulum</span></span></span></p>"
        },
        {
          "id": 62049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against the sarcoplasmic reticulum</span></span></span></p>"
        },
        {
          "id": 62050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accelerated uptake of the neurotransmitter at the nerve-muscle junction</span></span></span></p>"
        },
        {
          "id": 62051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 67-year-old male with a history of smoking and a recent diagnosis of small-cell lung carcinoma presents with a chief complaint of increasing weakness, particularly in the proximal muscles of his limbs. He reports that the weakness improves with repeated use of the muscles. Electromyography reveals a decremental response in muscle action potential amplitude with low-frequency stimulation, which improves with high-frequency stimulation. </span></span><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of muscle weakness in Lambert-Eaton syndrome is which of the following? </span></span></p>",
      "unique_key": "Q2087031",
      "question_audio": null,
      "question_video": null,
      "map_id": 32461,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans D) Antibody against presynaptic channels at the nerve-muscle junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario, <strong>weakness in the proximal muscle groups</strong>, associated with a <strong>pulmonary neoplasm </strong>with metastases, is consistent with <strong>Lambert-Eaton syndrome</strong> associated with <strong>small-cell carcinoma</strong>. In Lambert-Eaton syndrome, the tumor causes the production of an <strong><em>antibody directed against the presynaptic calcium channels</em></strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the correct mechanism. In <strong>Lambert-Eaton syndrome</strong>, <strong>antibodies </strong>target the <strong>voltage-gated calcium channels </strong>on the <strong>presynaptic terminal</strong>, <strong>impairing </strong>the <strong>release of acetylcholine</strong>, and thus leading to <strong>muscle weakness</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diminished calcium in the sarcoplasmic reticulum </strong>would <strong>affect muscle contraction </strong>but is <strong>not the mechanism of muscle weakness </strong>seen in Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>antibody against the sarcoplasmic reticulum</strong> is <strong>not associated with Lambert-Eaton syndrome</strong>. Antibodies in LEMS are directed against voltage-gated calcium channels on the presynaptic nerve terminal, not against the sarcoplasmic reticulum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accelerated uptake of neurotransmitter at the nerve-muscle junction</strong> would likely lead to a <strong>decrease in available neurotransmitter </strong>for <strong>muscle contraction</strong>, but this is not the pathophysiology of Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle weakness </strong>in <strong>Lambert-Eaton syndrome </strong>is due to <strong>antibodies against presynaptic voltage-gated calcium channels </strong>at the <strong>nerve-muscle junction</strong>, impairing acetylcholine release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1226</span></strong></span></span></p>",
      "correct_choice_id": 62051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}